CN107259036A - A kind of Xuancheng's pawpaw alternative tea and preparation method thereof - Google Patents

A kind of Xuancheng's pawpaw alternative tea and preparation method thereof Download PDF

Info

Publication number
CN107259036A
CN107259036A CN201710680241.9A CN201710680241A CN107259036A CN 107259036 A CN107259036 A CN 107259036A CN 201710680241 A CN201710680241 A CN 201710680241A CN 107259036 A CN107259036 A CN 107259036A
Authority
CN
China
Prior art keywords
parts
pawpaw
xuancheng
fruit
alternative tea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201710680241.9A
Other languages
Chinese (zh)
Inventor
陈家胜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningguo Balanced Health Management Co Ltd
Original Assignee
Ningguo Balanced Health Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ningguo Balanced Health Management Co Ltd filed Critical Ningguo Balanced Health Management Co Ltd
Priority to CN201710680241.9A priority Critical patent/CN107259036A/en
Publication of CN107259036A publication Critical patent/CN107259036A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/34Tea substitutes, e.g. matè; Extracts or infusions thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288Taraxacum (dandelion)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532Agastache, e.g. giant hyssop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/732Chaenomeles, e.g. flowering quince
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969Polygonatum (Solomon's seal)

Abstract

The present invention provides a kind of Xuancheng's pawpaw alternative tea, and it is prepared by the raw material of following parts by weight:20 35 parts of Xuancheng's pawpaw, 20 25 parts of purslane, 15 18 parts of fructus cannabis, 10 14 parts of the fruit of Chinese wolfberry, 10 18 parts of wrinkled giant hyssop, 16 18 parts of sealwort, 10 20 parts of dandelion, with raising resisting oxygen lack.

Description

A kind of Xuancheng's pawpaw alternative tea and preparation method thereof
Technical field
The present invention relates to food technology field, and in particular to a kind of Xuancheng's pawpaw alternative tea and preparation method thereof.
Background technology
Alternative tea refers to from leaf, flower, fruit (reality), rhizome of edible plants etc., using the drinking way of similar tealeaves The one class product of (being drunk by the mode such as steeping, boiling) is commonly called as.Alternative tea is divided into leaf class, flower class, fruit and tubers;It is same as The drinking way of tea, " integration of drinking and medicinal herbs class ", " can be used for health care productses " two classes typically as defined in the Ministry of Public Health in food classification Single or various article composition in article, the tea product being made of the root of these plants, stem, leaf or fruit.Existing market Upper alternative tea various types, but the real kind with raising resisting oxygen lack is seldom.
The content of the invention
Goal of the invention:In order to solve the above problems, it is an object of the invention to provide a kind of Xuancheng's pawpaw alternative tea and its system Preparation Method.
Technical scheme:The purpose of the present invention is realized by following scheme:
A kind of Xuancheng's pawpaw alternative tea, it is prepared by the raw material of following parts by weight:20-35 parts of Xuancheng's pawpaw, purslane 20-25 parts, 15-18 parts of fructus cannabis, 10-14 parts of the fruit of Chinese wolfberry, 10-18 parts of wrinkled giant hyssop, 16-18 parts of sealwort, 10-20 parts of dandelion.
The Xuancheng's pawpaw alternative tea, it is prepared by the raw material of following parts by weight:30 parts of Xuancheng's pawpaw, purslane 22 Part, 17 parts of fructus cannabis, 12 parts of the fruit of Chinese wolfberry, 14 parts of wrinkled giant hyssop, 17 parts of sealwort, 15 parts of dandelion.
The Xuancheng's pawpaw alternative tea, preparation method comprises the following steps:Take Xuancheng's pawpaw, purslane, fructus cannabis, the fruit of Chinese wolfberry, Wrinkled giant hyssop, sealwort, dandelion are ground into coarse powder, cross 20 mesh sieves, and packing is produced.
The Xuancheng's pawpaw alternative tea is preparing the application in improving anoxia tolerance function health food.
Beneficial effect:Xuancheng's pawpaw in the present invention, purslane suppressing the hyperactive liver and easing the stomach, relaxing muscles and tendons live muscle, it is clearing heat and detoxicating be monarch drug in a prescription, fire fiber crops Benevolence, the fruit of Chinese wolfberry, wrinkled giant hyssop are monarch drug in a prescription, and sealwort, dandelion are adjuvant medicine, and full side, which has, improves resisting oxygen lack.
Embodiment
Form, is described in further detail again to the above of the invention by the following examples, but should not be by this The scope for being interpreted as above-mentioned theme of the invention is only limitted to following example, and all technologies realized based on the above of the present invention are equal Belong to the scope of the present invention.
Embodiment 1:Take 20 parts of Xuancheng's pawpaw, 25 parts of purslane, 15 parts of fructus cannabis, 14 parts of the fruit of Chinese wolfberry, 10 parts of wrinkled giant hyssop, sealwort 18 Part, 10 parts of dandelion, wherein pawpaw, purslane, fructus cannabis, the fruit of Chinese wolfberry, wrinkled giant hyssop, sealwort, dandelion are ground into coarse powder, cross 20 mesh Sieve, packing, is produced.
Embodiment 2:Take 35 parts of Xuancheng's pawpaw, 20 parts of purslane, 18 parts of fructus cannabis, 10 parts of the fruit of Chinese wolfberry, 18 parts of wrinkled giant hyssop, sealwort 16 Part, 20 parts of dandelion, wherein pawpaw, purslane, fructus cannabis, the fruit of Chinese wolfberry, wrinkled giant hyssop, sealwort, dandelion are ground into coarse powder, cross 20 mesh Sieve, packing, is produced.
Embodiment 3:Take 30 parts of Xuancheng's pawpaw, 22 parts of purslane, 17 parts of fructus cannabis, 12 parts of the fruit of Chinese wolfberry, 14 parts of wrinkled giant hyssop, sealwort 17 Part, 15 parts of dandelion, wherein pawpaw, purslane, fructus cannabis, the fruit of Chinese wolfberry, wrinkled giant hyssop, sealwort, dandelion are ground into coarse powder, cross 20 mesh Sieve, packing, is produced.
Embodiment 4:The present invention improves the experiment influence of resisting oxygen lack
Experimental animal:Kunming mouse, male, body weight 18-22g, Shanghai Slac Experimental Animal Co., Ltd. provides, raw Produce licensing:SCXK (Shanghai) 2007-0005.
Experimental agents:Experimental article, the plain glue in positive drug gold day board heart source are prepared by above-described embodiment 1-3 preparation method Capsule, Xiamen Goldensun Technology Co., Ltd., hygienic food and health number (1999) the 0249th, lot number:20160123, calculated by per kilogram mouse, I.e. positive drug group gives golden day board heart source cellulose capsule 0.26g/kg.
Instrument and reagent:250mL ground wide-mouth bottles, operating scissors, 1mL syringes, stopwatch, vaseline, soda lime.
Oxygen deficit tolerance is tested:Healthy mice 50 is selected, 10 are separated at random and is only used as normal group, remaining 40 mouse, with Machine is divided into 4 groups:The golden day board heart source cellulose capsule group of high embodiment 1-3 groups, positive drug, wherein 3 dosage groups, the plain glue in golden day board heart source Capsule group press above-mentioned dosage gastric infusion, water of the normal group to 0.2ml, every morning 1 time, continuous 30d, last give experiment with by Thing is tried after 1 hour, mouse is respectively put into the 250mL ground wide-mouth bottles for filling 5g soda limes (every bottle of mouse);With all Intellectual circle smears bottleneck, covers tightly, is allowed to air tight;The immediate record time, stopped with breathing as index, record mouse is dead because of anoxic Die the time.
Influence ((X scholar D) of the present invention to the mouse normobaric hypoxia time-to-live
* p is compared with normal group<0.05;* is compared p with normal group<0.01
The normobaric hypoxia time-to-live of present invention group mouse is considerably longer than normal group, and with significant difference, illustrates this Invention, which has, improves anoxia endurance, and compared with positive drug, the time-to-live is long, illustrates to improve anoxia endurance effect better than the positive Medicine.

Claims (3)

1. a kind of Xuancheng's pawpaw alternative tea, it is characterised in that it is prepared by the raw material of following parts by weight:Xuancheng's pawpaw 20-35 Part, 20-25 parts of purslane, 15-18 parts of fructus cannabis, 10-14 parts of the fruit of Chinese wolfberry, 10-18 parts of wrinkled giant hyssop, 16-18 parts of sealwort, dandelion 10-20 parts.
2. Xuancheng's pawpaw alternative tea according to claim 1, it is characterised in that it is prepared into by the raw material of following parts by weight Arrive:30 parts of Xuancheng's pawpaw, 22 parts of purslane, 17 parts of fructus cannabis, 12 parts of the fruit of Chinese wolfberry, 14 parts of wrinkled giant hyssop, 17 parts of sealwort, 15 parts of dandelion.
3. Xuancheng's pawpaw alternative tea according to claim 1, it is characterised in that preparation method comprises the following steps:Take Xuancheng's pawpaw, Purslane, fructus cannabis, the fruit of Chinese wolfberry, wrinkled giant hyssop, sealwort, dandelion are ground into coarse powder, cross 20 mesh sieves, and packing is produced.
CN201710680241.9A 2017-08-10 2017-08-10 A kind of Xuancheng's pawpaw alternative tea and preparation method thereof Withdrawn CN107259036A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710680241.9A CN107259036A (en) 2017-08-10 2017-08-10 A kind of Xuancheng's pawpaw alternative tea and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710680241.9A CN107259036A (en) 2017-08-10 2017-08-10 A kind of Xuancheng's pawpaw alternative tea and preparation method thereof

Publications (1)

Publication Number Publication Date
CN107259036A true CN107259036A (en) 2017-10-20

Family

ID=60076992

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710680241.9A Withdrawn CN107259036A (en) 2017-08-10 2017-08-10 A kind of Xuancheng's pawpaw alternative tea and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107259036A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104814216A (en) * 2015-05-15 2015-08-05 合肥跃杰生态农业科技有限公司 Healthy tea capable of enhancing body immunity and preparation method thereof
CN106857976A (en) * 2016-06-22 2017-06-20 安徽明珍堂养生品有限公司 A kind of Xuancheng's pawpaw ginger tea and preparation method thereof
CN107006654A (en) * 2017-05-20 2017-08-04 宣城华科宣木瓜生物科技有限公司 Xuancheng's pawpaw ginger tea and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104814216A (en) * 2015-05-15 2015-08-05 合肥跃杰生态农业科技有限公司 Healthy tea capable of enhancing body immunity and preparation method thereof
CN106857976A (en) * 2016-06-22 2017-06-20 安徽明珍堂养生品有限公司 A kind of Xuancheng's pawpaw ginger tea and preparation method thereof
CN107006654A (en) * 2017-05-20 2017-08-04 宣城华科宣木瓜生物科技有限公司 Xuancheng's pawpaw ginger tea and preparation method thereof

Similar Documents

Publication Publication Date Title
Koul et al. The Artemisia genus: A review on traditional uses, phytochemical constituents, pharmacological properties and germplasm conservation
Dubreuil Antibacterial and antidiarrheal activities of plant products against enterotoxinogenic Escherichia coli
Modaresi et al. The effect of Taraxacum officinale hydroalcoholic extract on blood cells in mice
WO2006128032A2 (en) Compositions and methods for the prevention and treatment of conditions associated with inflammation
US20240050451A1 (en) Precision cannabinoid therapy formulations and methods of use
CN107233442A (en) It is a kind of that there is the composition and fingerprint for improving gout malaise symptoms
WO2009075488A2 (en) Anti-influenza viral composition containing bark or stem extract of alnus japonica
Sawarkar et al. Bamboos as a cultivated medicinal grass for industries: A systematic review
CN101658641A (en) Health-care preparation containing gastrodia tuer, folium cortex eucommiae, and Ilex latifolia thumb and preparation method thereof
CN107259036A (en) A kind of Xuancheng&#39;s pawpaw alternative tea and preparation method thereof
CN109432303A (en) A kind of effervescent tablet and preparation method thereof
CN101708231A (en) Blood pressure and blood fat reducing oral liquid used for improving sleep quality and preparation method thereof
Babar et al. Therapeutic Effect of Moringa Oleifera: A Review
CN113069511A (en) Granule for nourishing yin, nourishing viscera and cooling blood
CN110339304A (en) A kind of antidepression composite essential oil containing CBD ingredient
KR20130123947A (en) Immune enhancing and antiviral composition comprising extract of salvia miltiorrhiza bunge
Román et al. Physicochemical and Microbiological Assays for Quality Evaluation of a Brand of Mentha piperita Tisanes in Costa Rica Market: Employment of the Central American Technical Regulation
CN105687820A (en) Health product capable of reducing blood fat
CN101744242A (en) Composite soft capsule using seabuckthorm seed oil and evening primrose seed oil as main raw material and making method
CN102058048A (en) Buckwheat hard capsule formula
CN108935861A (en) A kind of fat decreasing tea and preparation method thereof
KR20140031459A (en) Composition for prevention or treatment of osteoarthritis including extracts of phyllanthus tenellus
CN109954047A (en) Relieving alcoholism and protecting liver health food
Verma A Review Study on Medicinal Properties of Psidium Guajava
CN108066447A (en) A kind of pharmaceutical composition for preventing depression and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20171020

WW01 Invention patent application withdrawn after publication